SPL Set ID: c8a93b32-0676-4704-86dc-cb65f425c6e5

1 drug(s) with this SPL Set ID

Open DailyMed details

VOYXACT SIBEPRENLIMAB
(SIBEPRENLIMAB) 400 mg/2 ml Injection
OTSUKA AMERICA PHARMACEUTICAL, INC. FDA Rx Only

VOYXACT contains sibeprenlimab-szsi, an A Proliferation Inducing Ligand (APRIL) blocker and humanized immunoglobulin G2 (IgG2) monoclonal antibody produced by Chinese Hamster Ovary (CHO) cells. The approximate molecular weight of sibeprenlimab-szsi is 146 kDa. VOYXACT (sibeprenlimab-szsi) injection is a sterile, preservative-free, clear to opalescent, colorless to yellow solution in a single-dose prefilled syringe for subcutaneous use. Each 2 mL prefilled syringe delivers 400 mg sibeprenlimab-szsi and the inactive ingredients: arginine (17.6 mg), glutamic acid (14.8 mg), histidine (4.34 mg), L-histidine hydrochloride monohydrate (4.62 mg), polysorbate 80 (0.40 mg), sorbitol (36.4 mg), and Water for Injection, USP. The pH is 6.2.

← Back to search